Martin L Brady1, Raghu Raghavan1, Jaime Mata2, Mike Wilson3, Scott Wilson3, Rick M Odland3,4, William C Broaddus5. 1. Therataxis LLC, Baltimore, Maryland, USA. 2. Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, Virginia, USA. 3. Twin Star TDS, Lexington, Kentucky, USA. 4. Hennepin County Medical Center, Minneapolis, Minnesota, USA. 5. Department of Neurosurgery, Medical College of Virginia/Virginia Commonwealth University, Richmond, Virginia, USA.
Abstract
BACKGROUND/AIMS: "Whole-brain" infusions have emerged as a potential need with the promise of disease-modifying therapies for neurodegenerative diseases. In addition, several current clinical trials in brain cancer utilize direct delivery of drugs that are required to fill large volumes. Such requirements may not be well served by conventional single port catheters with their "point source" of delivery. Our aim is to examine infusions into large volumes of heterogeneous tissue, aiming for uniformity of distribution. METHODS: A porous catheter (porous brain infusion catheter, PBIC), designed by Twin Star TDS LLC, for brain infusions was developed for this study and compared with another convection-enhanced delivery catheter (SmartFlowTM NGS-NC-03 from MRI Interventions, a step end-port catheter, SEPC) in current use in clinical trials. The studies were in vivo in porcine brain. A total of 8 pigs were used: the size of the pig brain limited the porous length to 15 mm. The placements of the tips of the two catheters were chosen to be the same (at the respective brain hemispheres). RESULTS: The PBIC and SEPC both performed comparably and well, with the PBIC having some advantage in effecting larger distributions: p ∼ 0.045, with 5 infusions from each. CONCLUSIONS: Given the performance of the PBIC, it would be highly appropriate to use the device for therapeutic infusions in human clinical trials to assess its capability for large-volume infusions.
BACKGROUND/AIMS: "Whole-brain" infusions have emerged as a potential need with the promise of disease-modifying therapies for neurodegenerative diseases. In addition, several current clinical trials in brain cancer utilize direct delivery of drugs that are required to fill large volumes. Such requirements may not be well served by conventional single port catheters with their "point source" of delivery. Our aim is to examine infusions into large volumes of heterogeneous tissue, aiming for uniformity of distribution. METHODS: A porous catheter (porous brain infusion catheter, PBIC), designed by Twin Star TDS LLC, for brain infusions was developed for this study and compared with another convection-enhanced delivery catheter (SmartFlowTM NGS-NC-03 from MRI Interventions, a step end-port catheter, SEPC) in current use in clinical trials. The studies were in vivo in porcine brain. A total of 8 pigs were used: the size of the pig brain limited the porous length to 15 mm. The placements of the tips of the two catheters were chosen to be the same (at the respective brain hemispheres). RESULTS: The PBIC and SEPC both performed comparably and well, with the PBIC having some advantage in effecting larger distributions: p ∼ 0.045, with 5 infusions from each. CONCLUSIONS: Given the performance of the PBIC, it would be highly appropriate to use the device for therapeutic infusions in human clinical trials to assess its capability for large-volume infusions.
Authors: Michal T Krauze; Ryuta Saito; Charles Noble; Matyas Tamas; John Bringas; John W Park; Mitchel S Berger; Krystof Bankiewicz Journal: J Neurosurg Date: 2005-11 Impact factor: 5.115
Authors: Martin L Brady; Raghu Raghavan; Deep Singh; P J Anand; Adam S Fleisher; Jaime Mata; William C Broaddus; William L Olbricht Journal: J Neurosci Methods Date: 2014-04-18 Impact factor: 2.390
Authors: R H Bobo; D W Laske; A Akbasak; P F Morrison; R L Dedrick; E H Oldfield Journal: Proc Natl Acad Sci U S A Date: 1994-03-15 Impact factor: 11.205
Authors: John H Sampson; Gary Archer; Christoph Pedain; Eva Wembacher-Schröder; Manfred Westphal; Sandeep Kunwar; Michael A Vogelbaum; April Coan; James E Herndon; Raghu Raghavan; Martin L Brady; David A Reardon; Allan H Friedman; Henry S Friedman; M Inmaculada Rodríguez-Ponce; Susan M Chang; Stephan Mittermeyer; David Croteau; Raj K Puri Journal: J Neurosurg Date: 2010-08 Impact factor: 5.115
Authors: Michael F Salvatore; Yi Ai; Brent Fischer; Amanda M Zhang; Richard C Grondin; Zhiming Zhang; Greg A Gerhardt; Don M Gash Journal: Exp Neurol Date: 2006-09-07 Impact factor: 5.330
Authors: Marina E Emborg; Valerie Joers; Ronald Fisher; Kevin Brunner; Victoria Carter; Chris Ross; Raghu Raghavan; Martin Brady; James Raschke; Ken Kubota; Andrew Alexander Journal: Cell Transplant Date: 2010-06-29 Impact factor: 4.064
Authors: John H Sampson; Martin L Brady; Neil A Petry; David Croteau; Allan H Friedman; Henry S Friedman; Terence Wong; Darell D Bigner; Ira Pastan; Raj K Puri; Christoph Pedain Journal: Neurosurgery Date: 2007-02 Impact factor: 4.654
Authors: John H Sampson; Martin Brady; Raghu Raghavan; Ankit I Mehta; Allan H Friedman; David A Reardon; Neil A Petry; Daniel P Barboriak; Terence Z Wong; Michael R Zalutsky; Denise Lally-Goss; Darell D Bigner Journal: Neurosurgery Date: 2011-09 Impact factor: 4.654